Foxn1 helps to determine whether pigment is deposited in the skin versus the hair, as the authors suggest, what regulates Foxn1 to give rise to such patterns? Finally, exactly how might Foxn1 act in an instructive way to stimulate pigment acquisition?
With regard to this last question, Weiner et al. find that Foxn1 regulates expression of fibroblast growth factor 2 (Fgf2), and that antibodies against Fgf2 prevent ectopic pigment cells from colonizing the epidermis of the transgenic mice that express Foxn1 in basal keratinocytes. In this context, Fgf2 may be acting like Kitl (Figure 1 ), that is, to stimulate migration and/or proliferation of melanocytes in such a way that they are recruited to, and remain in, the interfollicular epidermis. However, a mechanism mediating the potential role for the Foxn1-Fgf2 axis in the hair follicle would be different from that involving Kit1, because Foxn1 in the follicle affects the interactions between keratinocytes and melanocytes, not their numbers or location. Weiner et al. speculate that Foxn1 may "instruct" keratinocytes to receive pigment directly from melanocytes; unfortunately, there is almost nothing known about the cell biology of pigment transfer, and it is not clear how to test this idea. However, some simple experiments may prove illuminating. Given the previous work on Kit and Kitl, it is not known whether specification of the "pigment cell recipient phenotype" by Foxn1 requires Kit, a question that could be addressed using either a genetic approach or neutralizing antibodies. Another prediction of the authors' model is that specific expression of Foxn1 in suprabasal keratinocytes (using for example a Keratin 10 promoter) would cause pigment transfer to skip the basal layer of the epidermis and be directed instead to more superficial layers.
Regardless of the answer to these questions (which focus mainly on the epidermis and the relationship between Foxn1 and Kit signaling), the Weiner et al. study sheds light on one of the longstanding mysteries of the hair follicle: how the hair shaft gets its pigment. Clearly, making a complete hair follicle requires more than just building it.
Despite the importance of antimicrobial agents in the health care and agricultural sectors and almost a century of research and discovery, death of bacteria in response to antibiotic exposure largely remains a black box. We can readily measure the physiological effects of antibiotics, such as loss of membrane permeability and changes in cell morphology, as well as molecular events, such as inhibition of cellular pathways. However, the consequences for microbial molecular networks triggered by exposure to antibiotics that underlie these events remain obscure. Furthermore, it is not clear whether there is a single major mechanism of bacterial cell death from antibiotics or many. Is it possible that antibiotics with diverse chemical structures that have dissimilar cellular targets share downstream events in common that result in bacterial death? At a first approximation, one would predict that there are likely to be many consequences of inhibiting essential cellular processes and that, as a How do antibiotics actually work? Although the primary cellular targets of many antimicrobial agents have been identified, the downstream events leading to bacterial cell death remain unclear. In this issue, Kohanski et al. (2007) provide evidence that the production of reactive oxygen species is a shared mechanism of cell death initiated by bactericidal antibiotics.
result, there would be equally numerous ways to achieve bacterial killing. However, one could also imagine that events downstream of diverse antibiotics converge on a vital cellular hub. In this issue, Kohanski et al. (2007) provide evidence for such a hub in the action of bactericidal antibiotics-the production of reactive oxygen species. Using a clever fluorescence assay to measure production of hydroxyl radicals in bacterial cells, the authors explored the impact of known bactericidal antibiotics. These bactericidal antibiotics have different cellular targets: fluoroquinolones target topoisomerase, aminoglycosides target the ribosome, and β-lactams target peptidoglycan biosynthesis. Yet all three of these antibiotics induced the formation of reactive oxygen species when tested in both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria. In contrast, bacteriostatic antibiotics, which halt bacterial growth but do not trigger cell death, do not induce the production of hydroxyl radicals. The bacteriostatic antibiotics tested included inhibitors of translation (chloramphenicol, tetracycline, erythromycin, and spectinomycin) and transcription (rifamycin SV).
Using chemical rescue experiments (titration of bacterial cultures with the iron chelator 2,2′-dipyridyl or addition of the radical scavenger thiourea), Kohanski et al. were able to suppress the bactericidal, but not the bacteriostatic, effects of antibiotics. This experiment provides evidence that formation of hydroxyl radicals occurs via Fenton-like chemistry (oxidation of ferrous iron to ferric iron by peroxide, generating hydroxyl radicals). Additional support for this hypothesis includes evidence that the SOS response (an inducible DNA repair pathway that responds to DNA damage and oxidative stress) was initiated upon exposure to antibiotics and the observation that bacterial mutants impaired in the formation of iron-sulfur clusters (a logical source of iron) were less susceptible to bactericidal drugs. In addition, a marked depletion of NADH (a source of reducing power to generate ferrous iron) following exposure to bactericidal drugs was observed, and impairment of the tricarboxylic acid (TCA) cycle, which lowers the steady-state concentration of NADH, also made bacteria less susceptible to bactericidal drugs. This spike in hydroxyl radical formation results in DNA and protein damage, is common to all bactericidal antibiotics tested in the study, and is a unifying theme in death of bacteria (Figure 1) .
The new work by Kohanski et al. provides a theory of bacterial cell death induced by antibiotics wherein the inhibition of an essential process-for example, cell-wall synthesis-results in an increase in the concentration of intracellular hydroxyl radicals and damage to vital cell components (DNA, proteins, membranes). Furthermore, this work nicely builds on research showing that antibiotics such as ciprofloxacin also induce the SOS response and that the SOS response is a key step in the development of antibiotic resistance (Cirz et al., 2005 (Cirz et al., , 2006 . The SOS response includes the production of proteins involved in the repair of DNA damage such as RecA and protein folding agents such as chaperones. The repair of DNA damage is frequently accompanied by tolerance of minor gene mutations that can contribute to antibiotic resistance. Cell death and antibiotic resistance may therefore be connected through the production of hydroxyl radicals.
This growing body of evidence linking the action of antibiotics and the cellular response to macromolecular damage caused by hydroxyl radicals can now be exploited in the development of new antibacterial agents. Not only can inhibitors of the DNA damage response suppress the emergence of antibiotic resistance (especially when the drug is present in sublethal concentrations) (Cirz et al., 2005) ; as the work of Kohanski et al. suggests, such inhibitors may also potentiate the actions of bactericidal antibiotics. In fact, RecA inhibitors are currently under development (Lee et al., 2005) . This strategy should be applicable to any other key proteins in the response to hydroxyl radicals. These may have been overlooked in previous efforts to identify new potential targets of antibiotics, as they generally are not essential for cell growth. Furthermore, the facile fluorescence assay used by Kohanski et al. to detect hydroxyl radicals within cells could find use as an important secondary assay for rapid identification of candidate bactericidal antibiotics during screens for new agents.
The concept of antibiotic potentiation by compounds that inhibit important (though perhaps nonessential) metabolic pathways is a worthy alternative strategy to the "one compound, one target" approach that has dominated drug discovery. Although the development of antibiotics using this combinatorial approach presents challenges with respect to clinical trials and associated regulatory hurdles, it is instructive to recall that one of the most important and profitable antibiotics figure 1. common Mechanisms of Bacterial cell Death Induced by Antibiotics Antibiotics bind to their targets, disrupting normal cellular metabolism, including the tricarboxylic acid (TCA) cycle. This depletes intracellular NADH, which is paired with a commensurate rise in the production of reactive oxygen species such as peroxide and superoxide. These reactive oxygen species interact with Fe 2+ via Fenton chemistry to generate highly toxic oxygen radicals, which react with DNA and proteins, resulting in death of bacteria.
in current clinical use, Augmentin, is a combination of an inhibitor of drug resistance and an antibiotic. Inhibition of downstream repair efforts by bacteria in response to antibiotics could serve as the final knockout punch for bacterial pathogens.
